Topic: Fecal microbial transplantation

Nutr Cur 2023; 02: e012

Fecal microbiota transplantation: lights and shadows of a new weapon against inflammatory bowel disease

Treatment of inflammatory bowel disease (IBD) remains one of the most critical public health issues, mostly due to its wide global prevalence and dramatic impact on patients' quality of life.

Andrea Piccioni, Federico Rosa, Federica Manca, Davide Antonio Della Polla, Martina Petrucci, Benedetta Simeoni, Marcello Covino

Mar 08th, 2023

Nutr Cur 2023; 02: e001

Fecal microbiota transplantation: an update on the advances in the treatment of complex diseases

In addition to its proven effectiveness in the treatment of recurrent Clostridium difficile infections (rCDI), fecal microbiota transplantation (FMT) is on the rise to become one of the most studied...

Carlotta Magrì, Giuliana Calabrese, Letizia Masi, Sara Troisi, Federica di Vincenzo, Pierluigi Puca, Cristina Graziani, Loris R. Lopetuso, Valentina Petito

Jan 10th, 2023

Nutrimentum et Curae focuses on all issues related to body and mind health maintenance, and the search for all strategies – pharmacological and non-pharmacological – to find optimal nutritional and behavioral patterns for the population.

Nutrimentum et Curae is an Indicon S.r.l. Società Benefit (SB) project • Powered by Vivenko Srl Società Benefit Via Saffi, 10 – 20123 Milan • PEC: indicon@pec.it • Share capital 100.000,00 € i.v. • P.IVA/CF 11647700969 • REA MI n. 2616861

Testata registrata presso il Tribunale di Milano al nr. 11740/2022 num. Reg. Stampa 1.29 • Privacy Policy • Preferenze Cookies